# PFS-of-EGFR-mutated-NSCLC
PET/CT radiomics, PFS, TKI therapy

The excel includes significant radiomics and clinical data; it was used to identify stage IIIC/IV
EGFR-mutated non-small cell lung cancer populations sensitive to targeted therapy.

